(FM) Medicina Interna
Departamento académico
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (368)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
-
Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma
Biomolecules, Vol. 14, Núm. 6
-
Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality
Hepatology Communications, Vol. 8, Núm. 8
-
Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis
JHEP Reports, Vol. 6, Núm. 8
-
Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment
Journal of Physiology and Biochemistry
-
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Journal of Physiology and Biochemistry
-
Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma
Liver International
-
Dendritic Cells in Cancer Immunology and Immunotherapy
Cancers, Vol. 16, Núm. 5
-
Epicardial and liver fat implications in albuminuria: a retrospective study
Cardiovascular Diabetology, Vol. 23, Núm. 1
-
Evidence and choice: The BCLC vision for tailoring clinical decision-making
Journal of Hepatology
-
Exploring current and emerging therapies for porphyrias
Liver International, Vol. 44, Núm. 9, pp. 2174-2190
-
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Gut
-
MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver Fibrosis
Cellular and Molecular Gastroenterology and Hepatology, Vol. 17, Núm. 6, pp. 887-906
-
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU
Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 401-432
-
Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort
Science Advances, Vol. 10, Núm. 28
-
New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 5
-
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
Clinical science (London, England : 1979), Vol. 138, Núm. 20, pp. 1265-1284
-
Porphyrins and the porphyrias
Liver International
-
Refinement of paramagnetic bead-based digestion protocol for automatic sample preparation using an artificial neural network
Talanta, Vol. 274
-
Relationship between cholestasis and altered progesterone metabolism in the placenta-maternal liver tandem
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 2